David H. Holman
David H. Holman, Ph.D., is a director in Sterne Kessler’s Biotechnology & Chemical and Trial & Appellate Practice Groups. David has extensive experience in inter partes review proceedings and in the preparation and prosecution of U.S. and foreign patent applications. His technical expertise is in the areas of immunology, microbiology, and molecular biology.
David performed his graduate research under Dr. James Norris at the Medical University of South Carolina. David’s academic research focused on the characterization and use of small molecule inhibitors of ceramide metabolism for treating prostate cancer. He also explored the synergistic anti-cancer activity of these small molecules when combined with viral vector gene therapies.
After completing his doctoral research, David worked for two different start-up companies. His research efforts were in developing novel vaccines for infectious diseases and peptide therapeutics for certain illnesses. During his time in the private sector, David worked as a scientist during the day and attended law classes at night. He has authored or co-authored 19 peer-reviewed scientific publications and three book chapters. He also served as adjunct professor of biology at the College of Charleston.
Immediately prior to joining the firm, David served as the Technology Development Officer in the technology transfer office of a medical university. There, he assisted and advised faculty in protecting and commercializing university intellectual property. David also assisted in preparing confidential disclosure agreements, licensing/option agreements, and material transfer agreements.
David is also a contributing author of Patent Office Litigation, Second Edition, published in 2017 by Thomson Reuters Westlaw, the book provides a fresh and comprehensive exploration of patent office litigation proceedings, including how the proceedings interact with other aspects of patent procurement and enforcement, while delivering practical analysis and advice.
David received his J.D., magna cum laude, from the Charleston School of Law. He received his Ph.D. in microbiology and immunology from the Medical University of South Carolina and his B.S. in microbiology, cum laude, from Clemson University.